A Qualitative Study on the Pain and Quality of Life of Patients With Fabry Disease

Sponsor
Yonsei University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05679076
Collaborator
(none)
10
1
4
2.5

Study Details

Study Description

Brief Summary

Background It is necessary to find out the difficulties experienced by patients with Fabry disease and their families, and to seek solutions for them. For this purpose, qualitative research with a patient-centered approach is useful.

Objectives The Objective of this study is to understand the various difficulties of patients with Fabry disease and to help them establish a comprehensive support system, medical, health, and welfare service system, and develop the direction and components of social and educational programs.

Methods The subjects of this study are patients who have been diagnosed with Fabry disease, and among them, are selected considering the selection and exclusion criteria, confirm consent for participation in the study after sufficient explanation, and then enroll. The target number of subjects is 10 people. Subjects who consented to the study had an in-depth interview centered on the in-depth interview questionnaire through the HA Research Institute, a specialized institution.

  • The principle of saturation is observed by conducting 3 interviews per research subject.

  • The duration of each interview per research subject is 50 to 60 minutes.

  • All dictations of the research subjects were recorded with prior consent and then transcribed into a written copy.

  • For 3 interviews, the number of interviews can be reduced to 1 or 2 by extending the interview time according to the research subject's request.

  • As for the place of interview, the research counseling room at Severance Cardiovascular Hospital or the in-depth interview room in the HA Research Institute can be used, and the interview can be conducted at other places desired by the research subject at the request of the research subject.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    10 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    A Qualitative Study on the Pain and Quality of Life of Patients With Fabry Disease
    Actual Study Start Date :
    Jan 11, 2023
    Anticipated Primary Completion Date :
    May 12, 2023
    Anticipated Study Completion Date :
    May 12, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Fabry patients

    Fabry patients

    Outcome Measures

    Primary Outcome Measures

    1. Identify negative problems experienced by patients with Fabry disease [up to 5 months]

    2. Check the quality of life of patients with Fabry disease [up to 5 months]

    3. Identifying the structural causes of policies for patients with Fabry disease [up to 5 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    19 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Subjects who have delayed diagnosis of Fabry disease or have experienced treatment refusal.

    2. Subjects who have been diagnosed with Fabry name for more than 3 years or who have been treated for more than 1 year

    3. Adults between the ages of 19 and 70 who have the ability to consent to participate in the research (excluding those subject to adult guardianship) and have the cognitive ability to dictate their experiences

    4. Subjects who have experienced disadvantages and support in health-related quality of life, academic, job, family, social, and heterosexual relationships due to Fabry disease

    5. Subjects who voluntarily gave written consent after hearing the explanation of the purpose and method of this clinical study

    Exclusion Criteria:
    1. Subjects who, in the opinion of the researcher, are unlikely to complete the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine Seoul Korea, Republic of 03722

    Sponsors and Collaborators

    • Yonsei University

    Investigators

    • Principal Investigator: Geu-Ru Hong, Severance Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yonsei University
    ClinicalTrials.gov Identifier:
    NCT05679076
    Other Study ID Numbers:
    • 4-2022-1347
    First Posted:
    Jan 10, 2023
    Last Update Posted:
    Jan 20, 2023
    Last Verified:
    Jan 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 20, 2023